University of Auckland Leads $5.1M Drive to Eliminate Cervical Cancer in Pacific Region

Pacific-Led Cervical Cancer Elimination Initiative Backed by University of Auckland

  • higher-education-news
  • university-of-auckland
  • pacific-health
  • cervical-cancer-elimination
  • hpv-vaccination-pacific
New0 comments

Be one of the first to share your thoughts!

Add your comments now!

Have your say

Engagement level
A car driving down a road next to a bridge
Photo by Jacob R Vamseedhar G on Unsplash

Launch of the Groundbreaking Pacific Cervical Cancer Elimination Program

The University of Auckland has taken a leading role in a transformative health initiative, securing NZ$5.1 million from the Matariki Fund to spearhead efforts aimed at eliminating cervical cancer across the Pacific region. Announced in early March 2026, this program, led by the university's Te Poutoko Ora a Kiwa – Centre for Pacific and Global Health, marks a significant milestone in New Zealand's commitment to Pacific health equity. Administered by former Prime Minister Rt Hon Dame Jacinda Ardern, the funding – totaling NZ$5,097,210 over 2026–2031 – will support Pacific-led strategies to expand access to human papillomavirus (HPV) vaccination, cervical self-testing, diagnostics, and treatment. 77 78

This initiative builds on the World Health Organization's (WHO) Global Strategy to Eliminate Cervical Cancer, targeting the ambitious '90-70-90' goals by 2030: vaccinating 90% of girls by age 15 against HPV (the primary cause of cervical cancer), screening 70% of women by ages 35 and 45, and ensuring 90% of those with pre-cancerous lesions or invasive cancer receive timely treatment. By focusing initially on the Cook Islands and Niue, with plans to scale regionally, the program exemplifies how New Zealand universities are driving international health collaborations.

The Alarming Burden of Cervical Cancer in Pacific Communities

Cervical cancer remains a leading cause of cancer death among women in the Pacific, where incidence rates can be up to nine times higher than in Australasia, including New Zealand. 77 78 In some Pacific Islands, age-standardized rates exceed 50 per 100,000 women – far surpassing the global average of around 13 per 100,000. For context, the US-affiliated Pacific Islands like the Marshall Islands report rates between 58 and 83 per 100,000, highlighting systemic challenges such as limited screening infrastructure, low HPV vaccination coverage, and geographic isolation. 69

These disparities stem from human papillomavirus (HPV), a common sexually transmitted infection responsible for nearly all cervical cancers. Without intervention, the disease progresses silently from pre-cancerous lesions to invasive stages. In New Zealand, while national screening has reduced rates, Pacific women face barriers like cultural stigma, access issues, and lower participation – underscoring the need for tailored, region-specific approaches led by local expertise.

Chart showing cervical cancer incidence rates in Pacific Islands compared to New Zealand and Australia

The University of Auckland's involvement leverages its strengths in population health research, positioning it as a hub for addressing these inequities through evidence-based interventions.

Te Poutoko Ora a Kiwa: University of Auckland's Centre Driving Change

At the heart of this effort is Te Poutoko Ora a Kiwa, the University of Auckland's dedicated Centre for Pacific and Global Health. Co-directed by Professor Judith McCool, Head of the School of Population Health, and Professor Sir Collin Tukuitonga, the centre brings decades of expertise in Pacific health challenges. Their transdisciplinary approach integrates epidemiology, public health policy, and community engagement to tackle non-communicable diseases like cervical cancer.

Professor McCool emphasizes the shift to Pacific-led models: "This grant allows us to move beyond isolated interventions to a truly collaborative, Pacific-led approach. By strengthening leadership, governance, and regional partnerships, we are building the foundations for long-term health equity." 78 This aligns with the university's broader mission in global health, fostering research that translates into real-world impact. For aspiring researchers, the centre offers opportunities in clinical trials, data analysis, and policy development – key areas for higher education careers in New Zealand universities.

Dr Emma Carroll, a University of Auckland researcher and co-author of a systematic review on Pacific cervical cancer, provides critical data underscoring the urgency: incidence rates far exceed regional benchmarks, demanding immediate action. 77

Explore research positions in global health at New Zealand universities like those advancing Pacific health initiatives.

Core Strategies: From HPV Vaccination to Advanced Treatment

The program's multi-pronged strategy addresses the full cervical cancer prevention pathway, step by step:

  • HPV Vaccination Expansion: Targeting 90% coverage for girls by age 15, using single-dose regimens proven effective by WHO, to prevent initial infections.
  • Cervical Self-Testing Rollout: Introducing at-home HPV self-sampling kits, which have boosted participation in similar NZ programs among under-screened groups, aiming for 70% screening by ages 35 and 45.
  • Timely Diagnostics and Treatment: Enhancing access to colposcopy, biopsy, and thermal ablation for pre-cancerous lesions, alongside cryotherapy or surgery for invasive cases, ensuring 90% treatment rates.
  • Digital and System Infrastructure: Building data platforms for tracking and telemedicine to overcome geographic barriers.

These interventions, proven in Australia’s EPICC program, will be adapted culturally for Pacific contexts, emphasizing community trust and women's leadership.

A group of people sitting on top of a wooden platform

Photo by Nik Schmidt on Unsplash

Forging Strong Regional Partnerships and Leadership

Collaboration is key, with partners including Te Marae Ora (Cook Islands Ministry of Health), Niue Department of Health, the Australian-funded Elimination Partnership in the Indo-Pacific for Cervical Cancer (EPICC), and New Zealand's Polynesian Health Corridors. This network reduces duplication, shares best practices, and empowers Pacific women leaders through training in governance and workforce development.

Professor Sir Collin Tukuitonga notes: "Cervical cancer is preventable, yet too many Pacific women continue to die from it. This investment allows Pacific countries to work together – sharing expertise, strengthening systems, and supporting women leaders – to achieve elimination." 78 For University of Auckland students and faculty, this opens doors to fieldwork, interdisciplinary projects, and international networks – vital for careers in academic research.

Learn more about Te Poutoko Ora a Kiwa

Jacinda Ardern's Endorsement and Broader Support

Dame Jacinda Ardern, administering the Matariki Fund, champions the program: "Pacific women are disproportionately affected by a disease that can be eliminated. There is such excellent leadership within the region – this funding is simply about supporting them to save lives with solutions that should be available to everyone." 77 Her backing highlights New Zealand's soft power in Pacific health diplomacy, with the University of Auckland as a pivotal player.

This initiative complements national efforts, like NZ's own cervical screening transition to HPV primary testing, and positions UoA researchers at the forefront of global health innovation.

Aligning with WHO's Global Elimination Targets

The WHO strategy provides a roadmap: high vaccination prevents 90% of cases, screening detects early, and treatment averts progression. In the Western Pacific, 145,700 new cases and 74,900 deaths occurred in 2020 alone. 68 Pacific Islands face unique hurdles – remoteness, resource scarcity – but successes like Australia's near-elimination trajectory offer models.

University of Auckland's program scales these regionally, with monitoring via digital dashboards to track progress toward 2030 goals.

Opportunities for Higher Education and Research Careers

This project underscores the University of Auckland's prowess in Pacific health research, attracting funding and talent. It creates roles in epidemiology, health policy, clinical trials, and data science – ideal for postdocs, lecturers, and professors. NZ universities like UoA emphasize equitable partnerships, training Pacific scholars and fostering PhD opportunities in global health.

University of Auckland researchers collaborating on Pacific health projects

Stakeholders praise the initiative for building sustainable capacity. Interested in contributing? Browse university jobs in New Zealand's thriving health research sector or research positions focused on non-communicable diseases.

aerial view of city buildings during daytime

Photo by Kishan Modi on Unsplash

Challenges, Future Outlook, and Calls to Action

Challenges include sustaining funding post-2031, cultural adaptation, and supply chain logistics for vaccines/tests. Yet, with Pacific leadership, success is feasible – mirroring Australia's progress where rates dropped 39% since 2005.

Looking ahead, elimination could save thousands of lives annually, strengthening regional ties. For academics, this heralds expanded grants and collaborations. Stay informed via NZ higher education news, and consider rating professors in public health. Professionals can explore career advice or post openings at AcademicJobs.com recruitment.

Frequently Asked Questions

🏥What is the University of Auckland's role in the cervical cancer Pacific program?

Te Poutoko Ora a Kiwa leads the $5.1M initiative, focusing on HPV vaccination, self-testing, and treatment in Cook Islands/Niue, scaling regionally. Co-directors Prof Judith McCool & Prof Sir Collin Tukuitonga drive Pacific-led efforts.

💰How much funding supports this initiative and from where?

NZ$5.1 million (NZ$5,097,210) from Matariki Fund, administered by Dame Jacinda Ardern, over 2026–2031.

📈Why is cervical cancer a priority in the Pacific?

Rates up to 9x higher than NZ/Australia; leading cancer death for Pacific women due to low screening/vaccination. WHO notes Western Pacific: 145k cases/74k deaths in 2020.

🎯What are the WHO 90-70-90 targets for elimination?

  • 90% HPV vaccination by age 15
  • 70% screening by 35 & 45
  • 90% treatment for cases
UoA program aligns directly.

🌺Which countries will benefit first?

Cook Islands (Te Marae Ora) and Niue Dept of Health, expanding Pacific-wide with partners like EPICC (Australia).

🔬Who are the key researchers at University of Auckland?

Prof Judith McCool, Prof Sir Collin Tukuitonga (co-directors); Dr Emma Carroll (systematic review co-author). Centre fosters PhD/postdoc roles.

👏How does Dame Jacinda Ardern support the program?

Administers Matariki Fund; endorses as vital for Pacific women, praising regional leadership.

💼What career opportunities arise from this at NZ universities?

Roles in epidemiology, policy, trials. Check research jobs or career advice for global health paths.

⚠️What challenges does the program face?

Geography, stigma, sustained funding; addressed via digital tools, leadership training.

🤝How can researchers contribute to Pacific health at UoA?

Join Te Poutoko Ora a Kiwa projects; explore university jobs or NZ higher ed news for openings.

🦠What is HPV and its link to cervical cancer?

Human papillomavirus (HPV): virus causing 99% of cases; vaccines prevent infection effectively.